Loading
·
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.